(Press-News.org) In February of this year, Graphene Flagship associated member Graphenest and manufacturing company Hubron International entered a new strategic partnership. Their shared aim is to explore the development and commercialization of graphene-based polymer masterbatch and compounds with unprecedented electromagnetic interference (EMI) shielding performance for electronic enclosures manufacturing.
This new product line will start with a graphene-based thermoplastic suitable to be implemented as a remarkable EMI shielding solution in medium-high and high frequencies (for 5G and beyond).
The agreement brings together Graphenest’s knowledge around graphene production, the development of shielding products, and IP expertise, and Hubron International’s expertise as a specialist in black masterbatch and conductive polymers for Electric and Electronics parts.
An associated member of the Graphene Flagship since 2017, Graphenest is a nanotechnology company that has been involved in multiple pioneering endeavors – including the partnering project NeuroStimSpinal, which has been developing materials for the recovery of spinal cord injuries. Graphenest provides automotive and electronics sectors with conductive graphene-based EMI shielding solutions. Its primary objective is to replace metals with cost-effective, ultralightweight, and sustainable conductive coatings and plastic systems.
Hubron International is a leading global specialist in masterbatch. They have an extensive portfolio of specialist grades including conductive compounds, engineering masterbatches, specialist polymers, additive masterbatches with graphene, graphite and other materials to improve end-product properties and performance.
Thanks to new work in this space, the market is now able to use graphene-based shielding solutions to replace the conventional dense, rigid, and time and energy-intensive old-metal enclosures.
“The usage of polymeric compounds based on graphene that can effectively shield high concentrations of microwaves and millimeter waves (5G/6G) will be crucial in the near future,” says Bruno Figueiredo, Graphenest’s co-CEO.
“We are observing a rise in interest, mostly because more electronics and e-mobility devices are linking to one another. As a result, we can no longer completely rely on traditional, unsustainable metals.”
With this in mind, the collaboration between Graphenest and Hubron is especially welcome.
“The combination between Graphenest technology and Hubron’s masterbatch and compound expertise will boost the innovation towards the best conductive polymers, specially made for the E-mobility and Electronics industries”, says Robert Laurent, Technical Director of Hubron International.
Here at the Graphene Flagship, we are looking forward to seeing how this new collaboration will bring even more different coatings and plastic compound solutions into the market.
END
Graphenest and Hubron to explore development and commercialization of graphene
Graphenest and Hubron have entered a strategic partnership to explore the development and commercialization of graphene-based polymer masterbatch and compounds
2023-03-28
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
ENZAMET shows promise as prostate cancer treatment
2023-03-28
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) that operates within the University of Adelaide, have been published today in The Lancet Oncology.
For people with metastatic hormone-sensitive prostate cancer, the addition of an androgen receptor blocker with enzalutamide ...
Cancer that spreads to the lung maneuvers to avoid being attacked by “killer” T cells
2023-03-28
AUGUSTA, Ga. (March 28, 2023) – Cancer that has spread to areas like the lungs can apply the brakes to a natural pathway that should recruit killer T cells directly to where it has metastasized, scientists report.
That newly found strategy used by tumors that have spread — and are consequently more deadly — may help explain why sometimes promising immunotherapies designed to help the immune system kill cancer don’t, says Kebin Liu, PhD, cancer immunologist in the Department of Biochemistry and Molecular Biology at the Medical College of Georgia.
It also may mean an additional therapeutic maneuver is needed to stop some tumors, which ...
Hispanic, Black, and low-income adults are less likely to replace smoking with vaping
2023-03-27
FOR IMMEDIATE RELEASE
March 27, 2023
Contact:
Jillian McKoy, jpmckoy@bu.edu
Michael Saunders, msaunder@bu.edu
##
Growing evidence suggests that e-cigarettes may serve as a less harmful alternative to smoking traditional cigarettes, but socioeconomic and racial inequities in cigarette and e-cigarette use are preventing certain populations from reaping these potential health benefits, according to a new study led by Boston University School of Public Health (BUSPH) and the Keck School of Medicine of the University of Southern California (Keck School of Medicine of USC).
Published in the American Journal of Preventive ...
Rare beetle, rediscovered after 55 years, named in honor of Jerry Brown
2023-03-27
Berkeley — When University of California, Berkeley, entomologist Kipling Will first heard that former Gov. Jerry Brown was hosting field scientists on his Colusa County ranch, he jumped at the chance to hunt for beetles on the property.
“I reached out and said, ‘Hey, I want to sample your beetles,’” Will said. “And [Brown] was quite game to let me come up there.”
Will, a professor of environmental science, policy and management, has travelled to all corners of California ...
JNM explores potential applications for ChatGPT in nuclear medicine and molecular imaging
2023-03-27
Reston, VA—A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging. In the article, Irène Buvat, PhD, and Wolfgang Weber, MD, PhD, report on discussions they held with ChatGPT regarding several nuclear medicine and molecular imaging topics and provide their commentary on the pros and cons of using the chatbot.
Developed by OpenAI, ChatGPT is a natural language processing chatbot that can intelligently respond to questions. ...
Aging | Parsing chronological and biological age effects on vaccine responses
2023-03-27
“Ultimately, while both chronological and biological age appear to be important determinants of vaccine-preventable outcomes in older adults, the underlying context and mechanisms of their effects remain unclear.”
BUFFALO, NY- March 27, 2023 – A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 5, entitled, “Parsing chronological and biological age effects on vaccine responses.”
Researchers ...
Beneficial bacteria in the infant gut uses nitrogen from breast milk to support baby’s health
2023-03-27
A University of Massachusetts Amherst nutrition scientist who has spent his career studying breast milk has demonstrated how beneficial microbes in the gut of infants use nitrogen from human milk to support pediatric nutrition and development.
“The molecules in breast milk not only feed the baby but also feed the baby’s microbiome,” says David Sela, associate professor of food science and director of the Fergus M. Clydesdale Center for Foods for Health and Wellness. “This ...
Study finds neighborhood apps increase perceptions of crime rates
2023-03-27
How often do you glance at your neighborhood app, like Nextdoor or others, and learn about some crime in your area? Surely, it was not the intention of the app developers, but every time you hear of a crime nearby you might think that crime in your area is rampant. A new study by a University of Houston psychologist indicates that is exactly how the mind works – those helpful and popular neighborhood apps are actually increasing perceptions of crime rates that may not be as high as you think.
“Neighborhood ...
Can cannabis use disorder be accurately diagnosed?
2023-03-27
Cannabis use disorder is defined by the Diagnostic and Statistical Manual of Mental Disorders as a problematic pattern leading to clinically significant impairment or distress, with symptoms that may include increased tolerance, withdrawal symptoms, strong desire to use marijuana and spending large amounts of time using cannabis.
Tammy Chung, director of the Center for Population Behavioral Health at Rutgers Institute for Health, Health Care Policy and Aging Research, along with colleagues Marc Steinberg of Rutgers Robert Wood Johnson Medical School and Mary Barna Bridgeman of the Rutgers ...
SCAI and HRS release expert consensus on transcatheter left atrial appendage closure
2023-03-27
WASHINGTON (March 27, 2023) – Today, the Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) released an updated expert consensus statement on transcatheter left atrial appendage closure (LAAC). SCAI and HRS prioritized the development of an updated consensus statement to provide recommendations on contemporary, evidence-based best practices for transcatheter LAAC focusing on endovascular devices.
Left atrial appendage closure is a minimally invasive procedure that is used to reduce the risk of stroke associated with atrial fibrillation. ...
LAST 30 PRESS RELEASES:
Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education
Development of a novel modified selective medium cefixime–tellurite-phosphate-xylose-rhamnose MacConkey agar for isolation of Escherichia albertii and its evaluation with food samples
KIST develops full-color-emitting upconversion nanoparticle technology for color displays with ultra-high color reproducibility
Towards a fully automated approach for assessing English proficiency
Increase in alcohol deaths in England an ‘acute crisis’
Government urged to tackle inequality in ‘low-carbon tech’ like solar panels and electric cars
Moffitt-led international study finds new drug delivery system effective against rare eye cancer
Boston stroke neurologist elected new American Academy of Neurology president
Center for Open Science launches collaborative health research replication initiative
Crystal L. Mackall, MD, FAACR, recognized with the 2025 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
A novel strategy for detecting trace-level nanoplastics in aquatic environments: Multi-feature machine learning-enhanced SERS quantification leveraging the coffee ring effect
Blending the old and the new: Phase-change perovskite enable traditional VCSEL to achieve low-threshold, tunable single-mode lasers
Enhanced photoacoustic microscopy with physics-embedded degeneration learning
Light boosts exciton transport in organic molecular crystal
On-chip multi-channel near-far field terahertz vortices with parity breaking and active modulation
The generation of avoided-mode-crossing soliton microcombs
Unlocking the vibrant photonic realm: A new horizon for structural colors
Integrated photonic polarizers with 2D reduced graphene oxide
Shouldering the burden of how to treat shoulder pain
Stevens researchers put glycemic response modeling on a data diet
Genotype-to-phenotype map of human pelvis illuminates evolutionary tradeoffs between walking and childbirth
Pleistocene-age Denisovan male identified in Taiwan
KATRIN experiment sets most precise upper limit on neutrino mass: 0.45 eV
How the cerebellum controls tongue movements to grab food
It’s not you—it’s cancer
Drug pollution alters migration behavior in salmon
Scientists decode citrus greening resistance and develop AI-assisted treatment
Venom characteristics of a deadly snake can be predicted from local climate
Brain pathway links inflammation to loss of motivation, energy in advanced cancer
Researchers discover large dormant virus can be reactivated in model green alga
[Press-News.org] Graphenest and Hubron to explore development and commercialization of grapheneGraphenest and Hubron have entered a strategic partnership to explore the development and commercialization of graphene-based polymer masterbatch and compounds